[{"address1": "2222 Ponce de Leon Blvd.", "address2": "Floor 3", "city": "Coral Gables", "state": "FL", "zip": "33134", "country": "United States", "phone": "786 629 1376", "website": "https://www.relmada.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sergio  Traversa M.B.A., Pharm.D.", "age": 64, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 1800723, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maged S. Shenouda M.B.A., R.Ph.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 993750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul E. Kelly M.B.A.", "age": 67, "title": "COO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 872780, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles S. Ence CPA, M.B.A.", "age": 59, "title": "Chief Accounting & Compliance Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 983039, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gina  DiGuglielmo", "title": "VP & Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raj S. Pruthi F.A.C.S., M.D., M.H.A.", "age": 57, "title": "Chief Medical Officer of Urology", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Cutler", "title": "Senior Clinical Development Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard M. Mangano Ph.D.", "age": 74, "title": "Consultant", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 9, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6072, "open": 0.61, "dayLow": 0.5902, "dayHigh": 0.6604, "regularMarketPreviousClose": 0.6072, "regularMarketOpen": 0.61, "regularMarketDayLow": 0.5902, "regularMarketDayHigh": 0.6604, "payoutRatio": 0.0, "beta": 0.666, "forwardPE": -0.32144278, "volume": 182085, "regularMarketVolume": 182085, "averageVolume": 400645, "averageVolume10days": 167650, "averageDailyVolume10Day": 167650, "bid": 0.462, "ask": 0.793, "bidSize": 2, "askSize": 2, "marketCap": 21445092, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 3.98, "fiftyDayAverage": 0.64378, "twoHundredDayAverage": 0.8106, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 825566, "profitMargins": 0.0, "floatShares": 24521638, "sharesOutstanding": 33191600, "sharesShort": 401305, "sharesShortPriorMonth": 595028, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0121, "heldPercentInsiders": 0.16995001, "heldPercentInstitutions": 0.29954, "shortRatio": 1.97, "shortPercentOfFloat": 0.0124, "impliedSharesOutstanding": 33191600, "bookValue": 0.481, "priceToBook": 1.3432432, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -67809016, "trailingEps": -2.2, "forwardEps": -2.01, "lastSplitFactor": "1:4", "lastSplitDate": 1569801600, "52WeekChange": -0.7764706, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 0.6461, "targetHighPrice": 1.0, "targetLowPrice": 1.0, "targetMeanPrice": 1.0, "targetMedianPrice": 1.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 20619540, "totalCashPerShare": 0.621, "totalDebt": 0, "quickRatio": 4.016, "currentRatio": 4.108, "returnOnAssets": -0.95669997, "returnOnEquity": -1.7512399, "freeCashflow": -25782928, "operatingCashflow": -49924936, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Relmada Therapeutics, Inc.", "longName": "Relmada Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1403271000000, "postMarketChangePercent": 0.0, "postMarketPrice": 0.6461, "postMarketChange": 0.0, "regularMarketChange": 0.0389, "regularMarketDayRange": "0.5902 - 0.6604", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 400645, "marketState": "CLOSED", "fiftyTwoWeekLowChange": 0.40609998, "fiftyTwoWeekLowChangePercent": 1.6920832, "fiftyTwoWeekRange": "0.24 - 3.98", "fiftyTwoWeekHighChange": -3.3339, "fiftyTwoWeekHighChangePercent": -0.8376633, "fiftyTwoWeekChangePercent": -77.64706, "dividendDate": 1569801600, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.2, "epsForward": -2.01, "epsCurrentYear": -1.15, "priceEpsCurrentYear": -0.5618261, "fiftyDayAverageChange": 0.0023199916, "fiftyDayAverageChangePercent": 0.0036037026, "twoHundredDayAverageChange": -0.1645, "twoHundredDayAverageChangePercent": -0.2029361, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 6.40645, "regularMarketPrice": 0.6461, "corporateActions": [], "postMarketTime": 1755301238, "regularMarketTime": 1755288000, "exchange": "NCM", "messageBoardId": "finmb_9070579", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Relmada Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]